Sections

Services

Information

US United States

Tamiflu

Articles (1 - 8 of 8)

Conflicting recommendations about flu drugs has made it difficult for doctors to decide whether to prescribe them. Andrew Wales/Flickr

What kind of research can we trust?

Research involving pharmaceutical company input is notoriously compromised. While not all industry ties lead to biased research, and not all biases are a consequence of industry ties, many studies show…
Big pharma: a world of many faces. Greg Peverill-Conti

Glaxo: the new modern face of big pharma?

With billions to be made on the back of ill health and notable scandals and cover-ups in its history, it’s fair to say that many see the public face of the pharmaceutical industry as a mask for darker…
Tamiflu was stockpiled amid flu outbreaks and scares. Rui Vieira/PA

Tamiflu cost us £424m yet we still don’t know much about it

Are you worried about how decisions involving public money are made? You should be. Last week, the National Audit Office disclosed that the Department of Health spent £424 million on the anti-flu drug…
Non-publication of clinical trial data is a waste of research resources, among other things. Esther Dyson

Register all trials, report all results – it’s long overdue

If researchers go to the effort of getting funds, recruiting patients, and following them up, you would think that they would be keen to publish the results. So it’s surprising that our best estimates…
Does Tamiflu work the way its manufacturer claims?

Drug trial results must be made public

A team of public health experts has called for the release of all clinical drug trial results for independent analysis following…

Top contributors

More